Mysimba
Mysimba is a weight-loss medication containing bupropion and naltrexone that is being recalled across the European Union due to adverse events. This recall is classified as Class II, meaning the product could cause serious health problems but is unlikely to result in death. The recall affects all users of this medication in EU countries.
- Product
- Active substances: bupropion hydrochloride;naltrexone hydrochloride. ATC code: A08AA
- Reason
- Adverse event
- Classification
- Class II
- Category
- drug recall
- Country
- European Union
- Agency
- EMA-DHPC
- Recall date
- 2025-05-29
- Status
- Ongoing
- Distribution
- European Union
Official recall notice from EMA-DHPC
Recall details on Nibble Recalls: https://trynibble.app/recalls/ab1456a4-7437-4ae2-b0f8-ff6e64eea715